Basiliximab vs Low-dose Thymoglobulin Induction Therapy in Low Risk Kidney Transplant Patients

NCT03006419 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

100

Enrollment

OTHER_GOV

Sponsor class

Conditions

Kidney Transplant Rejection
Kidney Transplant; Complications

Interventions

DRUG: Basiliximab
DRUG: Thymoglobulin

Sponsor

Coordinación de Investigación en Salud, Mexico